|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
153,922,000 |
Market
Cap: |
6.15(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$37.79 - $39.95 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
Total People Sold |
0 |
0 |
1 |
5 |
Total Sell Transactions |
0 |
0 |
2 |
30 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2015-12-01 |
4 |
AS |
$63.21 |
$126,482 |
D/D |
(2,000) |
0 |
|
- |
|
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2015-12-01 |
4 |
OE |
$24.49 |
$48,980 |
D/D |
2,000 |
2,000 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-11-30 |
4 |
AS |
$61.08 |
$1,161,132 |
D/D |
(18,582) |
29,910 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-11-30 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
48,492 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-11-24 |
4 |
AS |
$60.14 |
$1,640,318 |
D/D |
(27,215) |
278,605 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-11-24 |
4 |
OE |
$1.65 |
$806,152 |
D/D |
27,215 |
305,820 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-18 |
4 |
AS |
$60.00 |
$30,000 |
I/I |
(500) |
5,945 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-18 |
4 |
AS |
$60.00 |
$60,000 |
D/D |
(1,000) |
9,684 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-10 |
4 |
AS |
$58.69 |
$29,345 |
I/I |
(500) |
6,445 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-10 |
4 |
AS |
$58.69 |
$58,690 |
D/D |
(1,000) |
10,684 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-09 |
4 |
AS |
$60.00 |
$30,000 |
I/I |
(500) |
6,945 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-09 |
4 |
AS |
$60.00 |
$60,000 |
D/D |
(1,000) |
11,684 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-11-05 |
4 |
S |
$53.06 |
$1,107,767 |
D/D |
(20,687) |
278,605 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-11-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
299,292 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-02 |
4 |
AS |
$54.00 |
$27,000 |
I/I |
(500) |
7,445 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-11-02 |
4 |
AS |
$54.00 |
$54,000 |
D/D |
(1,000) |
13,184 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-10-30 |
4 |
AS |
$49.88 |
$926,909 |
D/D |
(18,582) |
29,910 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-10-30 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
48,492 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-10-21 |
4 |
AS |
$42.52 |
$1,177,713 |
D/D |
(27,215) |
259,292 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-10-21 |
4 |
OE |
$13.22 |
$844,364 |
D/D |
27,215 |
286,507 |
|
- |
|
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2015-10-16 |
4 |
AS |
$45.00 |
$90,000 |
D/D |
(2,000) |
0 |
|
- |
|
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2015-10-16 |
4 |
OE |
$24.49 |
$48,980 |
D/D |
2,000 |
2,000 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-09-29 |
4 |
AS |
$36.37 |
$700,438 |
D/D |
(18,582) |
29,910 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-09-29 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
48,492 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-09-21 |
4 |
AS |
$45.26 |
$1,261,208 |
D/D |
(27,215) |
259,292 |
|
- |
|
494 Records found
|
|
Page 14 of 20 |
|
|